STOCK TITAN

Surmodics to Participate in the Piper Sandler Healthcare Conference on November 28

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Surmodics, Inc. (SRDX) to Participate in 35th Annual Piper Sandler Healthcare Conference. The company's management will present at the conference on November 28, 2023, and a live webcast of the presentation will be available on the company's website.
Positive
  • None.
Negative
  • None.

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)-- Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that management will participate in the 35th Annual Piper Sandler Healthcare Conference, which is being held at the Lotte New York Palace in New York, NY from November 28-30, 2023. Management will present on Tuesday, November 28, at 8:30 a.m. ET (7:30 a.m. CT).

A live webcast of the presentation can be accessed by going to “Events & Presentations” under the “Investors” section of the company’s website at https://surmodics.gcs-web.com/events-and-presentations, and clicking on the webcast icon under “Upcoming Events.” A replay of the webcast will be archived on the website for the following 90 days.

About Surmodics, Inc.

Surmodics is a leading provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays. Surmodics also develops and commercializes highly differentiated vascular intervention medical devices that are designed to address unmet clinical needs and engineered to the most demanding requirements. This key growth strategy leverages the combination of the Company’s expertise in proprietary surface modification and drug-delivery coating technologies, along with its device design, development, and manufacturing capabilities. The Company’s mission is to improve the detection and treatment of disease. Surmodics is headquartered in Eden Prairie, Minnesota. For more information, visit www.surmodics.com. The content of Surmodics’ website is not part of this press release or part of any filings that the company makes with the Securities and Exchange Commission.

Surmodics Investor Inquiries:

Jack Powell, Investor Relations

ir@surmodics.com

Source: Surmodics, Inc.

FAQ

When is Surmodics, Inc. participating in the 35th Annual Piper Sandler Healthcare Conference?

Surmodics, Inc. will be participating in the conference on November 28, 2023.

Where can I access the live webcast of Surmodics, Inc.'s presentation?

The live webcast will be available on the 'Events & Presentations' section of the company's website at https://surmodics.gcs-web.com/events-and-presentations.

How long will the webcast be available for replay?

A replay of the webcast will be archived on the company's website for the following 90 days.

Surmodics, Inc.

NASDAQ:SRDX

SRDX Rankings

SRDX Latest News

SRDX Stock Data

485.98M
10.61M
3.75%
91.43%
3.14%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
EDEN PRAIRIE

About SRDX

surmodics partners with the world's leading and emerging medical device, diagnostic and life sciences companies to develop and commercialize innovative products designed to improve lives by enabling the detection and treatment of disease. following two recent acquisitions, the company is transforming its medical device business from being a provider of coating technologies, to offering whole-product solutions. throughout its transformation, surmodics’ mission remains: to improve the detection and treatment of disease by using our technology to provide solutions to difficult medical device and diagnostic challenges.